Therapeutic interventions such as oral immunotherapy and administration of low-dose interleukin-2 (IL-2) have been shown to enhance Treg functionality, thereby representing promising strategies for the management of food allergies such as peanut allergy [11]. This evidence concerns the gene IL2 and peanut allergic reaction.